NASDAQ:TNDM - Tandem Diabetes Care Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$14.20 +0.37 (+2.68 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$13.83
Today's Range$13.45 - $14.59
52-Week Range$2.14 - $14.59
Volume1.73 million shs
Average Volume1.69 million shs
Market Capitalization$688.43 million
P/E Ratio-1.10
Dividend YieldN/A
Beta-0.4

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company, which designs, develops and commercializes products for people with insulin dependent diabetes. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Receive TNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TNDM
CUSIPN/A
Phone858-366-6900

Debt

Debt-to-Equity Ratio6.45
Current Ratio2.62
Quick Ratio2.01

Price-To-Earnings

Trailing P/E Ratio-1.10
Forward P/E Ratio-9.79
P/E GrowthN/A

Sales & Book Value

Annual Sales$107.60 million
Price / Sales6.61
Cash FlowN/A
Price / CashN/A
Book Value$0.24 per share
Price / Book59.17

Profitability

EPS (Most Recent Fiscal Year)($12.87)
Net Income$-73,030,000.00
Net Margins-70.69%
Return on EquityN/A
Return on Assets-63.52%

Miscellaneous

Employees574
Outstanding Shares50,070,000

Tandem Diabetes Care (NASDAQ:TNDM) Frequently Asked Questions

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Shares of Tandem Diabetes Care reverse split before market open on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care (NASDAQ:TNDM) announced its quarterly earnings results on Thursday, March, 1st. The medical device company reported ($1.23) EPS for the quarter, missing analysts' consensus estimates of ($1.11) by $0.13. The medical device company earned $40 million during the quarter, compared to analysts' expectations of $38.41 million. The company's revenue for the quarter was up 61.3% on a year-over-year basis. During the same period last year, the company earned ($0.48) earnings per share. View Tandem Diabetes Care's Earnings History.

When is Tandem Diabetes Care's next earnings date?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Tandem Diabetes Care.

What price target have analysts set for TNDM?

7 brokerages have issued 1 year target prices for Tandem Diabetes Care's stock. Their forecasts range from $3.00 to $17.00. On average, they anticipate Tandem Diabetes Care's share price to reach $9.9167 in the next year. View Analyst Ratings for Tandem Diabetes Care.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:
  • Kim D. Blickenstaff, President, Chief Executive Officer & Director
  • John F. Sheridan, Chief Operating Officer & Executive Vice President
  • Leigh Vosseller, Chief Financial Officer & Senior Vice President
  • David B. Berger, Secretary, Executive VP & General Counsel
  • Brian B. Hansen, Chief Commercial Officer & Executive VP

Has Tandem Diabetes Care been receiving favorable news coverage?

Media stories about TNDM stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tandem Diabetes Care earned a news sentiment score of 0.08 on Accern's scale. They also gave news articles about the medical device company an impact score of 46.30 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Tandem Diabetes Care's major shareholders?

Tandem Diabetes Care's stock is owned by a variety of of retail and institutional investors. Top institutional investors include First Light Asset Management LLC (9.46%), Frontier Capital Management Co. LLC (5.43%), Federated Investors Inc. PA (4.49%), Acuta Capital Partners LLC (2.69%), Wasatch Advisors Inc. (1.81%) and Millennium Management LLC (1.70%). Company insiders that own Tandem Diabetes Care stock include Christopher J Twomey, Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.

Which institutional investors are buying Tandem Diabetes Care stock?

TNDM stock was purchased by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, Federated Investors Inc. PA, Frontier Capital Management Co. LLC, Acuta Capital Partners LLC, Millennium Management LLC, venBio Select Advisor LLC, Wasatch Advisors Inc. and Millrace Asset Group Inc.. Company insiders that have bought Tandem Diabetes Care stock in the last two years include Christopher J Twomey, Dick Allen and Kim D Blickenstaff. View Insider Buying and Selling for Tandem Diabetes Care.

How do I buy shares of Tandem Diabetes Care?

Shares of TNDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of TNDM stock can currently be purchased for approximately $14.20.

How big of a company is Tandem Diabetes Care?

Tandem Diabetes Care has a market capitalization of $688.43 million and generates $107.60 million in revenue each year. The medical device company earns $-73,030,000.00 in net income (profit) each year or ($12.87) on an earnings per share basis. Tandem Diabetes Care employs 574 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11075 ROSELLE STREET, San Diego CA, 92121. The medical device company can be reached via phone at 858-366-6900 or via email at [email protected]


MarketBeat Community Rating for Tandem Diabetes Care (TNDM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  231 (Vote Outperform)
Underperform Votes:  260 (Vote Underperform)
Total Votes:  491
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe TNDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNDM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Tandem Diabetes Care in the last 12 months. Their average twelve-month price target is $9.9167, suggesting that the stock has a possible downside of 30.16%. The high price target for TNDM is $17.00 and the low price target for TNDM is $3.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.862.632.332.33
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.9167$9.6429$13.00$13.00
Price Target Upside: 30.16% downside74.69% upside343.69% upside343.69% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/21/2018OppenheimerSet Price TargetBuy$10.00 ➝ $15.00HighView Rating Details
5/14/2018Piper Jaffray CompaniesUpgradeNeutral ➝ OverweightHighView Rating Details
3/28/2018CowenUpgradeMarket Perform ➝ OutperformMediumView Rating Details
3/23/2018Robert W. BairdUpgradeNeutral ➝ OutperformHighView Rating Details
3/2/2018Stifel NicolausReiterated RatingHold$4.00HighView Rating Details
2/27/2018CitigroupInitiated CoverageOutperform$5.50LowView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 ➝ $17.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche BankLower Price TargetBuy$140.00 ➝ $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy ➝ BuyN/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Tandem Diabetes Care (NASDAQ:TNDM) Earnings History and Estimates Chart

Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Earnings Estimates

2018 EPS Consensus Estimate: ($1.16)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.34)($0.34)($0.34)
Q2 20183($0.34)($0.28)($0.31)
Q3 20183($0.28)($0.28)($0.28)
Q4 20183($0.28)($0.20)($0.23)
Q2 20191($0.27)($0.27)($0.27)
Q3 20191($0.18)($0.18)($0.18)
Q4 20191($0.07)($0.07)($0.07)

Tandem Diabetes Care (NASDAQ TNDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2018($0.37)N/AView Earnings Details
4/26/2018Q1 2018($0.59)($1.03)$25.32 million$27.30 millionViewN/AView Earnings Details
3/1/2018Q4 2017($1.1050)($1.2310)$38.41 million$40.00 millionViewListenView Earnings Details
10/26/2017Q3 2017($3.74)($3.09)$25.92 million$27.00 millionViewN/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
11/1/2016Q3 2016($5.90)($9.70)$23.42 million$12.29 millionViewN/AView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
3/6/2014Q4 2013($13.10)($16.00)$8.64 million$10.25 millionViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tandem Diabetes Care (NASDAQ:TNDM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.30%
Institutional Ownership Percentage: 47.09%
Insider Trading History for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Trading History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2018Dick AllenDirectorBuy25,539$3.88$99,091.32View SEC Filing  
2/9/2018Christopher J TwomeyDirectorBuy75,000$2.00$150,000.00View SEC Filing  
2/9/2018Kim D BlickenstaffCEOBuy750,000$2.00$1,500,000.00View SEC Filing  
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.002,007,939View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.0022,763View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.007,295View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.007,295View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.009,295View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.004,084View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.004,084View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.004,084View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tandem Diabetes Care (NASDAQ TNDM) News Headlines

Source:
DateHeadline
FY2020 EPS Estimates for Tandem Diabetes Care (TNDM) Raised by AnalystFY2020 EPS Estimates for Tandem Diabetes Care (TNDM) Raised by Analyst
www.americanbankingnews.com - May 23 at 7:52 AM
Tandem Diabetes Care Stock Rose 44% Last WeekTandem Diabetes Care Stock Rose 44% Last Week
finance.yahoo.com - May 22 at 8:19 AM
Tandem Diabetes Care (TNDM) PT Set at $15.00 by OppenheimerTandem Diabetes Care (TNDM) PT Set at $15.00 by Oppenheimer
www.americanbankingnews.com - May 21 at 11:05 AM
Piper Jaffray Brokers Cut Earnings Estimates for Tandem Diabetes Care (TNDM)Piper Jaffray Brokers Cut Earnings Estimates for Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - May 16 at 6:56 AM
Tandem Diabetes Care (TNDM) Upgraded by ValuEngine to "Buy"Tandem Diabetes Care (TNDM) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - May 15 at 1:21 PM
Piper Jaffray: Tandem Diabetes Is Entering A Goldilocks PeriodPiper Jaffray: Tandem Diabetes Is Entering A 'Goldilocks Period'
www.msn.com - May 14 at 5:19 PM
Tandem Diabetes Care (TNDM) Has Climbed To An 8-Month HighTandem Diabetes Care (TNDM) Has Climbed To An 8-Month High
www.nasdaq.com - May 14 at 5:19 PM
Here's Why Tandem Diabetes Care, Inc. Is Rising TodayHere's Why Tandem Diabetes Care, Inc. Is Rising Today
finance.yahoo.com - May 14 at 5:19 PM
Piper Jaffray Upgrades Tandem Diabetes Care (TNDM) to OverweightPiper Jaffray Upgrades Tandem Diabetes Care (TNDM) to Overweight
www.americanbankingnews.com - May 14 at 12:32 PM
Heres Why Tandem Diabetes Care, Inc. Is Rising TodayHere's Why Tandem Diabetes Care, Inc. Is Rising Today
www.fool.com - May 14 at 12:28 PM
Tandem Diabetes Care (TNDM) Receives Average Rating of "Buy" from BrokeragesTandem Diabetes Care (TNDM) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 13 at 10:13 AM
Tandem Diabetes Care (TNDM) Expected to Announce Quarterly Sales of $29.94 MillionTandem Diabetes Care (TNDM) Expected to Announce Quarterly Sales of $29.94 Million
www.americanbankingnews.com - May 12 at 4:30 AM
Zacks: Brokerages Expect Tandem Diabetes Care (TNDM) to Post -$0.35 EPSZacks: Brokerages Expect Tandem Diabetes Care (TNDM) to Post -$0.35 EPS
www.americanbankingnews.com - May 10 at 5:27 AM
Tandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare ConferenceTandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
finance.yahoo.com - May 9 at 5:33 PM
Tandem Diabetes Care (TNDM) Rating Lowered to Hold at Zacks Investment ResearchTandem Diabetes Care (TNDM) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - May 4 at 12:10 AM
Tandem Diabetes Care to Present at the Deutsche Bank 43rd Annual Health Care ConferenceTandem Diabetes Care to Present at the Deutsche Bank 43rd Annual Health Care Conference
finance.yahoo.com - May 1 at 5:17 PM
Tandem Diabetes Cares t:slim X2 CE MarkdTandem Diabetes Care's t:slim X2 CE Mark'd
seekingalpha.com - April 30 at 5:13 PM
Tandem Diabetes Cares (TNDM) CEO Kim Blickenstaff on Q1 2018 Results - Earnings Call TranscriptTandem Diabetes Care's (TNDM) CEO Kim Blickenstaff on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 28 at 8:31 AM
Tandem Diabetes Care (TNDM) Lowered to Sell at ValuEngineTandem Diabetes Care (TNDM) Lowered to Sell at ValuEngine
www.americanbankingnews.com - April 27 at 10:20 PM
Edited Transcript of TNDM earnings conference call or presentation 26-Apr-18 8:30pm GMTEdited Transcript of TNDM earnings conference call or presentation 26-Apr-18 8:30pm GMT
finance.yahoo.com - April 27 at 5:14 PM
Form S-3 TANDEM DIABETES CAREForm S-3 TANDEM DIABETES CARE
www.streetinsider.com - April 27 at 8:30 AM
Form DEF 14A TANDEM DIABETES CARE For: Jun 14Form DEF 14A TANDEM DIABETES CARE For: Jun 14
www.streetinsider.com - April 27 at 8:30 AM
BRIEF-Tandem Diabetes Care Reports Qtrly Net Loss Per Share, Basic And Diluted Of $1.82BRIEF-Tandem Diabetes Care Reports Qtrly Net Loss Per Share, Basic And Diluted Of $1.82
www.reuters.com - April 27 at 8:30 AM
BRIEF-Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 MlnBRIEF-Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 Mln
www.reuters.com - April 27 at 8:30 AM
Tandem Diabetes Care (TNDM) Releases Quarterly  Earnings ResultsTandem Diabetes Care (TNDM) Releases Quarterly Earnings Results
www.americanbankingnews.com - April 26 at 10:28 PM
Tandem Diabetes Care EPS of -$1.82Tandem Diabetes Care EPS of -$1.82
seekingalpha.com - April 26 at 5:16 PM
Tandem Diabetes Care Reports First Quarter 2018 Financial ResultsTandem Diabetes Care Reports First Quarter 2018 Financial Results
finance.yahoo.com - April 26 at 5:16 PM
Technical Perspectives on Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Retractable Technologies, and Tandem Diabetes CareTechnical Perspectives on Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Retractable Technologies, and Tandem Diabetes Care
www.bizjournals.com - April 25 at 8:21 AM
Tandem Diabetes Care (TNDM): Moving Average Crossover AlertTandem Diabetes Care (TNDM): Moving Average Crossover Alert
finance.yahoo.com - April 25 at 8:21 AM
Tandem Diabetes Care +3.5% on Australia, New Zealand distribution dealsTandem Diabetes Care +3.5% on Australia, New Zealand distribution deals
seekingalpha.com - April 23 at 11:18 PM
Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New ZealandTandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand
finance.yahoo.com - April 23 at 5:13 PM
Pivotal Point For Tandem Diabetes CarePivotal Point For Tandem Diabetes Care
seekingalpha.com - April 20 at 5:21 PM
Tandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference CallTandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference Call
finance.yahoo.com - April 18 at 5:44 PM
Tandem Diabetes Care (TNDM) Given Consensus Rating of "Buy" by BrokeragesTandem Diabetes Care (TNDM) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 18 at 9:07 AM
Tandem Diabetes Care (TNDM) Scheduled to Post Quarterly Earnings on WednesdayTandem Diabetes Care (TNDM) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 4:20 AM
Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done YetTandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet
investorplace.com - April 13 at 11:45 AM
Tandem Diabetes (TNDM) Reports Prelim. Q1 Sales of $27MTandem Diabetes (TNDM) Reports Prelim. Q1 Sales of $27M
www.streetinsider.com - April 12 at 5:38 PM
Tandem Diabetes Care (TNDM) Upgraded at BidaskClubTandem Diabetes Care (TNDM) Upgraded at BidaskClub
www.americanbankingnews.com - April 11 at 11:01 AM
Tandem Diabetes Care Announces Preliminary First Quarter 2018 ResultsTandem Diabetes Care Announces Preliminary First Quarter 2018 Results
finance.yahoo.com - April 10 at 5:29 PM
Tandem Diabetes Care Inc (NASDAQ:TNDM): Are Analysts Bullish?Tandem Diabetes Care Inc (NASDAQ:TNDM): Are Analysts Bullish?
finance.yahoo.com - April 10 at 5:29 PM
Why Tandem Diabetes Care Is Soaring 18.5% Higher TodayWhy Tandem Diabetes Care Is Soaring 18.5% Higher Today
finance.yahoo.com - April 10 at 5:29 PM
25 Stocks Moving In Tuesdays Mid-Day Session25 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - April 10 at 1:27 PM
Tandem Diabetes sees 42% increase in Q1 sales; shares ahead 2% premarketTandem Diabetes sees 42% increase in Q1 sales; shares ahead 2% premarket
seekingalpha.com - April 10 at 9:42 AM
Tandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 7 at 10:52 AM
Tandem Diabetes Care (TNDM) Upgraded at ValuEngineTandem Diabetes Care (TNDM) Upgraded at ValuEngine
www.americanbankingnews.com - April 7 at 7:02 AM
Tandem Diabetes Care (TNDM) Expected to Post Quarterly Sales of $25.15 MillionTandem Diabetes Care (TNDM) Expected to Post Quarterly Sales of $25.15 Million
www.americanbankingnews.com - April 7 at 2:08 AM
Tandem Diabetes Care (TNDM) Cut to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 9:50 PM
Tandem Diabetes Care (TNDM) Given a $8.00 Price Target at OppenheimerTandem Diabetes Care (TNDM) Given a $8.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 6 at 11:06 AM
-$0.60 EPS Expected for Tandem Diabetes Care (TNDM) This Quarter-$0.60 EPS Expected for Tandem Diabetes Care (TNDM) This Quarter
www.americanbankingnews.com - April 5 at 9:14 PM
Tandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment ResearchTandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 5 at 2:58 PM

SEC Filings

Tandem Diabetes Care (NASDAQ:TNDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tandem Diabetes Care (NASDAQ:TNDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tandem Diabetes Care (NASDAQ TNDM) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.